Showing results (201-210 of 657) with videos related to
Sort By:
Pageof 66
Contraception|February 28, 2020
Exploring crowdfunding campaigns for abortion servicesMichael T Solotke, Nicole Brussel Faria, Hasna Karim, et al.Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box WarningsMichael T Solotke, Joseph S Ross, Nilay D Shah, et al.The New England Journal of Medicine|April 1, 2008
Use of ezetimibe in the United States and CanadaCynthia A Jackevicius, Jack V Tu, Joseph S Ross, et al.Psychiatric Services (Washington, D.C.)|October 23, 2024
National Trends in and Concentration of Industry Payments to U.S. Psychiatrists, 2015-2021John L Havlik, Lydia Ososanya, Deanna Tang, et al.Annals of Internal Medicine|October 7, 2024
Modernizing Medical Device Regulation: Challenges and Opportunities for the 510(k) Clearance ProcessKushal T Kadakia, Vinay K Rathi, Sanket S Dhruva, et al.JAMA Network Open|December 6, 2021
Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare BeneficiariesKevin M Wheelock, Joseph S Ross, Karthik Murugiah, et al.BMC Medicine|June 18, 2019
Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysisJoshua D Wallach, Anita T Luxkaranayagam, Sanket S Dhruva, et al.American Heart Journal|July 6, 2010
Beyond insurance coverage: usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination SurveyErica S Spatz, Joseph S Ross, Mayur M Desai, et al.JAMA Internal Medicine|January 11, 2013
When choosing statin therapy: the case for genericsJonas B Green, Joseph S Ross, Cynthia A Jackevicius, et al.JAMA Network Open|May 11, 2019
Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or CommitmentsJoshua J Skydel, Anita T Luxkaranayagam, Sanket S Dhruva, et al.Pageof 66